Lupus alpha Asset Management AG (-) 13-Apr-2022 / 18:00 CET/CEST
Dissemination of a Regulatory Announcement, transmitted by EQS
Group. The issuer is solely responsible for the content of this
announcement.
-----------------------------------------------------------------------------------------------------------------------
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1%
OR MORE
Rule 8.3 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Full name of discloser: Lupus alpha Asset Management AG
(b) Owner or controller of interests and short positions
disclosed, if different from 1(a):
The naming of nominee or vehicle companies is
insufficient. For a trust, the trustee(s), settlor and
beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant
securities this form relates: Sensyne Health PLC
Use a separate form for each offeror/offeree
(d) If an exempt fund manager connected with an offeror/
offeree, state this and specify identity of offeror/
offeree:
08.04.2022
(e) Date position held/dealing undertaken:
(in addition Lupus alpha Asset Management AG has dealt on
For an opening position disclosure, state the latest previous dates during the offer period as attached at the
practicable date prior to the disclosure end of this form).
(f) In addition to the company in 1(c) above, is the
discloser making disclosures in respect of any other party N/A
to the offer?
If YES, specify which:
If it is a cash offer or possible cash offer, state "N/A"
2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
If there are positions or rights to subscribe to disclose in
more than one class of relevant securities of the offeror or
offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for
each additional class of relevant security.
(a) Interests and short positions in the relevant securities of
the offeror or offeree to which the disclosure relates following
the dealing (if any)
Class of relevant security:
Ordinary shares
Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled: 0 0.00
(2) Cash-settled derivatives:
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:
0 0.00
TOTAL:
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions
(including traded options), or agreements to purchase or sell
relevant securities, should be given on a Supplemental Form 8 (Open
Positions).
(b) Rights to subscribe for new securities (including directors'
and other employee options)
Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
Where there have been dealings in more than one class of
relevant securities of the offeror or offeree named in 1 (c), copy
table 3(a), (b), (c) or (d) (as appropriate) for each additional
class of relevant security dealt in.
The currency of all prices and other monetary amounts should be
stated.
(a) Purchases and sales
Purchase/sale
Class of relevant security Number of securities Price per unit
1,400,000 0.0219 GBP
Ordinary shares 500,000 0.0219 GBP
Sale
300,000 0.0219 GBP
Ordinary shares Sale 290.000 0.0219 GBP
Lupus alpha Asset Management AG did not have discretion
regarding voting decisions in respect of 290,000 shares that were
sold on 08/04/2022 of which 70.000 shares were purchased on
09/11/2021
(b) Cash-settled derivative transactions
Product Nature of dealing
Class of relevant description Number of reference Price per
security e.g. opening/closing a long/short position, increasing/ securities unit
e.g. CFD reducing a long/short position
(c) Stock-settled derivative transactions (including
options)
(i) Writing, selling, purchasing or varying
Type
Class of Product Writing, Number of securities Exercise Option money
relevant description e.g. purchasing, to which option price per e.g. Expiry paid/ received
security call option selling, varying relates unit American, date per unit
etc. European
etc.
(ii) Exercise
Class of relevant Product description Exercising/ exercised
security against Number of securities Exercise price per unit
e.g. call option
(d) Other dealings (including subscribing for new
securities)
Nature of dealing
Class of relevant security Details Price per unit (if applicable)
e.g. subscription, conversion
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to
relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the
disclosure and any party to the offer or any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or
understandings, state "none"
None
(b) Agreements, arrangements or understandings relating to
options or derivatives
Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure
and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is
referenced:
If there are no such agreements, arrangements or understandings, state "none"
None
(c) Attachments
Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 13.04.2022
Contact name: Davor Dubovina
Telephone number*: 004969 36 50 58 7264
Public disclosures under Rule 8 of the Code must be made to a
Regulatory Information Service.
The Panel's Market Surveillance Unit is available for
consultation in relation to the Code's disclosure requirements on
+44 (0)20 7638 0129.
*If the discloser is a natural person, a telephone number does
not need to be included, provided contact information has been
provided to the Panel's Market Surveillance Unit.
The Code can be viewed on the Panel's website at
www.thetakeoverpanel.org.uk.
Purchases and sales
Purchase/sale
Date Class of relevant security Number of securities Price per unit
09.11.2021 490,000 0.9876 GBP
Ordinary shares Purchase
70,000 0.9876 GBP
09.11.2021
Ordinary shares Purchase 70.000 0.9876 GBP
Purchase
10.11.2021 500,000
Ordinary shares 0.99 GBP
-----------------------------------------------------------------------------------------------------------------------
Category Code: RET - Sensyne Health PLC
TIDM: -
LEI Code: 529900JRIM4CXFEUZK50
Sequence No.: 155546
EQS News ID: 1327507
End of Announcement EQS News Service
=------------------------------------------------------------------------------------
Image link:
https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1327507&application_name=news
(END) Dow Jones Newswires
April 13, 2022 12:00 ET (16:00 GMT)
Sensyne Health (LSE:SENS)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Sensyne Health (LSE:SENS)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024
